GO
Loading...

BMRN CEO on Kuvan

Monday, 17 Dec 2007 | 6:53 PM ET

FDA approves BioMarin's Kuvan drug, with Jean-Jacques Bienaime, BioMarin CEO, and Mad Money host Jim Cramer.